Avoro Capital Advisors LLC Has $261.01 Million Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Avoro Capital Advisors LLC grew its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 15.6% during the 4th quarter, HoldingsChannel reports. The firm owned 5,666,666 shares of the biopharmaceutical company’s stock after acquiring an additional 766,666 shares during the quarter. Xenon Pharmaceuticals comprises about 3.6% of Avoro Capital Advisors LLC’s investment portfolio, making […]

Related Keywords

Canada , , News Ratings For Xenon Pharmaceuticals Daily , Citigroup , Advisors Asset Management Inc , Nasdaq , Avoro Capital Advisors , Xenon Pharmaceuticals Inc , Xenon Pharmaceuticals Profile , Cantor Fitzgerald , Xenon Pharmaceuticals , Tower Research Capital , Royal Bank , Quarter For Xenon Pharmaceuticals , Needham Company , Barclays Plc , Xenon Pharmaceuticals Stock , Free Report , Capital Advisors , Research Capital , Asset Management , Aigen Investment Management , Get Free Report , Pharmaceuticals Inc , Visit Holdingschannel , Xenon Pharmaceuticals Daily ,